Literature DB >> 6373586

Hemodynamic and endocrine changes associated with potassium supplementation in sodium-loaded hypertensives.

T Fujita, K Ando.   

Abstract

To clarify the mechanism by which potassium (KCl) protects against the blood pressure rising action of sodium (NaCl), we studied the effects of KCl loading in patients with idiopathic hypertension who, after a period of NaCl restriction, partook of a high NaCl diet. Eleven patients who had taken the KCl supplement (96 mEq/day) during the high NaCl period showed lesser mean blood pressure (MAP) rise with changes in NaCl intake from 25 to 250 mEq/day than 12 patients who had not taken the KCl supplement (p less than 0.001). With a high NaCl diet, the KCl-supplemented patients retained less NaCl, gained less weight, and showed a lesser increase in plasma volume and cardiac output than the non-KCl-supplemented ones. Overall, the increase in blood pressure levels during the high Na diet correlated directly either with changes in plasma volume (p less than 0.05) or with changes in cardiac output (p less than 0.01). The results suggest that KCl may prevent a rise in blood pressure with NaCl loads in hypertensive patients by attenuating the increase in cardiac output, mainly as a result of the natriuresis. Furthermore, plasma norepinephrine was measured to estimate the sympathetic activity, since the sympathetic nervous system is known to control urinary NaCl excretion. From the low NaCl diet to Day 3 of the high NaCl diet, plasma norepinephrine was significantly (p less than 0.01) decreased in the KCl-supplemented patients, whereas it remained unchanged in the non-KCl-supplemented ones.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6373586

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

Review 1.  Sodium-to-potassium ratio and blood pressure, hypertension, and related factors.

Authors:  Vanessa Perez; Ellen T Chang
Journal:  Adv Nutr       Date:  2014-11-14       Impact factor: 8.701

2.  Association of dietary sodium and potassium intakes with albuminuria in normal-weight, overweight, and obese participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Kristal J Aaron; Ruth C Campbell; Suzanne E Judd; Paul W Sanders; Paul Muntner
Journal:  Am J Clin Nutr       Date:  2011-08-31       Impact factor: 7.045

Review 3.  Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems.

Authors:  Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

4.  Controlled trial of long term oral potassium supplements in patients with mild hypertension.

Authors:  A Siani; P Strazzullo; L Russo; S Guglielmi; L Iacoviello; L A Ferrara; M Mancini
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-06

5.  Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats.

Authors:  T Fujita; I Hayashi; Y Kumagai; N Inamura; M Majima
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 6.  Hypertension in the elderly: a Japanese perspective.

Authors:  Toshio Ogihara; Hiromi Rakugi
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 7.  Does Potassium Deficiency Contribute to Hypertension in Children and Adolescents?

Authors:  Bonita Falkner
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

Review 8.  Physical activity in human hypertension. A mechanisms approach.

Authors:  W L Kenney; E J Zambraski
Journal:  Sports Med       Date:  1984 Nov-Dec       Impact factor: 11.136

9.  Improvement of cardiovascular effects of metoprolol by replacement of common salt with a potassium- and magnesium-enriched salt alternative.

Authors:  E M Mervaala; J Laakso; H Vapaatalo; H Karppanen
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

10.  Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates.

Authors:  T Fujita; Y Sato
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.